The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Inventiva S.A. (NASDAQ:IVA) is one of the 10 best stocks under $10 offering more than 50% upside.

As of the June 24 close, Inventiva S.A. (NASDAQ:IVA) had a strongly bullish consensus sentiment. The stock received Buy ratings from all 9 analysts who provided coverage. Based on a 1-year median price target of $15.75, it currently offers a huge upside potential of over 325%.

Copyright: nexusplexus / 123RF Stock Photo

On June 12, Inventiva S.A. (NASDAQ:IVA) shared updates on some of its recently announced financing arrangements. The company fully repaid roughly €62 million of its existing EIB loans, which included the principal amount and accrued interest on the loans.

The company also executed a buyback and subsequent cancellation of its warrants linked to around 22.7 million EIB shares. This included all Tranche A warrants and 700,000 Tranche B warrants, adding up to a total repurchase price of €50 million.

The company also carried out a €75 million drawdown through debt financing with its lenders, i.e., Claret Capital Partners and BlackRock. This included an amount of €35 million in Tranche A Senior Secured Convertible Debt and €40 million in Tranche B Senior Secured Amortized Debt.

Conversion price applicable on Tranche A Convertible Bonds is €5.2893, representing a 40% premium on the EURO-denominated offer price for the stock ADS.

Inventiva S.A. (NASDAQ:IVA) is a clinical-stage biopharmaceutical company. The company is focused on developing oral small-molecule therapies in France and worldwide. It develops Odiparcil and Lanifibranor. The company is also involved in the development of TGF-ß, which is used for treating idiopathic pulmonary fibrosis.

While we acknowledge the potential of IVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.